Aspen Neuroscience, Inc. insider Peter A. Thompson purchases $15M in ASPE shares
The purchase raises the insider's holding by 39%, the filing shows.
A director at Aspen Neuroscience, Inc., Peter A. Thompson, bought 1,000,000 shares of the company's stock on the open market on Nov 2. The purchase, at an average of $15.00 a share, comes to $15 million.
The purchase was made in the open market, not through an award, an option exercise or a plan. With this purchase the insider holds 3,589,132 shares, 39% more than before.
Other Aspen Neuroscience, Inc. insiders have also bought: Four insiders made open-market purchases within 14 days, a pattern known as a cluster buy. The trade was reported within two business days, as Section 16 requires.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Aspen Neuroscience, Inc. (ASPE) |
|---|---|
| Insider | Peter A. Thompson |
| Role | Director |
| Transaction | Open-market purchase (code P) |
| Shares | 1,000,000 |
| Average price | $15.00 |
| Value | $15,000,000 |
| Trade date | Nov 2, 2026 |
| Filed with the SEC | Nov 4, 2026, 6:47 PM ET |
| Shares held after | 3,589,132 |
| Ownership | Indirect |
| Rule 10b5-1 plan | Not marked in the filing |
See the full details of this insider trade
Browse the latest insider buying · Browse the insider trading newsroom
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
